45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
1,997
Insurances with rates
16
CPT / HCPCS codes
1,941
Most expensive procedures (gross)
J2350
$86,199
Ocrelizumab 300 Mg/10 Ml
Gross
$88,864
J2350
$86,199
Ocrelizumab 300 Mg/10 Ml
Gross
$88,864
J2329
$45,761
Ublituximab-Xiiy 150 Mg/6 Ml
Gross
$47,176
J2329
$45,761
Ublituximab-Xiiy 150 Mg/6 Ml
Gross
$47,176
J9119
$45,241
Cemiplimab-Rwlc 350 Mg/7 Ml Vl
Gross
$46,640
J9119
$45,241
Cemiplimab-Rwlc 350 Mg/7 Ml Vl
Gross
$46,640
J9144
$43,825
Daratumumab Hyaluronida 1800Mg
Gross
$45,180
J9144
$43,825
Daratumumab Hyaluronida 1800Mg
Gross
$45,180
J9316
$38,897
Pertuzu-Trastuzu 10 Ml Vial
Gross
$40,100
J9316
$38,897
Pertuzu-Trastuzu 10 Ml Vial
Gross
$40,100
J3380
$38,525
Vedolizumab 300 MG Vial
Gross
$39,716
J3380
$38,525
Vedolizumab 300 MG Vial
Gross
$39,716
J3101
$30,637
Tenecteplase 50 Mg/10 Ml Syrng
Gross
$31,584
J3101
$30,637
Tenecteplase 50 Mg/10 Ml Syrng
Gross
$31,584
81162
$27,682
BRCA 1&2 Full Gene Seq Del/Dup
Gross
$28,538
81162
$27,682
BRCA 1&2 Full Gene Seq Del/Dup
Gross
$28,538
J0717
$21,524
Certolizumab Pegol 400 Mg Kit
Gross
$22,189
J0717
$21,524
Certolizumab Pegol 400 Mg Kit
Gross
$22,189
J0896
$17,293
Luspatercept-Aamt 25 Mg Vial
Gross
$17,827
J0896
$17,293
Luspatercept-Aamt 25 Mg Vial
Gross
$17,827
J2356
$16,938
Tezepelumab-EKKO 210 Mg/1.9 Ml
Gross
$17,461
J2356
$16,938
Tezepelumab-EKKO 210 Mg/1.9 Ml
Gross
$17,461
J2182
$13,027
Mepolizumab 100 MG Vial
Gross
$13,430
J2182
$13,027
Mepolizumab 100 MG Vial
Gross
$13,430
J9205
$12,472
Irinotecan Lipos 43MG/10ML Vl
Gross
$12,857
J9205
$12,472
Irinotecan Lipos 43MG/10ML Vl
Gross
$12,857
J2357
$12,236
Omalizumab 300 Mg/2Ml Syringe
Gross
$12,614
J2357
$12,236
Omalizumab 300 Mg/2Ml Syringe
Gross
$12,614
Q5107
$11,812
Bevacizumab-AWWB 400Mg/16Ml Vi
Gross
$12,177
Q5107
$11,812
Bevacizumab-AWWB 400Mg/16Ml Vi
Gross
$12,177
J3111
$11,169
Romosozumab-AQQG 210 Mg/2.34Ml
Gross
$11,514
J3111
$11,169
Romosozumab-AQQG 210 Mg/2.34Ml
Gross
$11,514
78815
$10,791
PET CT Skull To Mid Thigh Init
Gross
$11,125
78815
$10,791
PET CT Skull To Mid Thigh Init
Gross
$11,125
Q5111
$8,657
Pegfilgrastim-Cbqv 6 Mg/0.6 Ml
Gross
$8,925
Q5111
$8,657
Pegfilgrastim-Cbqv 6 Mg/0.6 Ml
Gross
$8,925
J1602
$8,577
Golimumab 50 MG/4 ML Vial
Gross
$8,842
J1602
$8,577
Golimumab 50 MG/4 ML Vial
Gross
$8,842
J9034
$8,459
Bendamustine 100 Mg/4 Ml Vial
Gross
$8,720
J9034
$8,459
Bendamustine 100 Mg/4 Ml Vial
Gross
$8,720
Q5122
$8,285
Pegfilgrastim 6 Mg/0.6 Ml Syr
Gross
$8,541
Q5122
$8,285
Pegfilgrastim 6 Mg/0.6 Ml Syr
Gross
$8,541
81352
$8,111
TP53 Somatic Mutation, Prog
Gross
$8,362
81352
$8,111
TP53 Somatic Mutation, Prog
Gross
$8,362
Q5108
$7,786
Pegfilgrastim-Jmdb 6 Mg/0.6 Ml
Gross
$8,026
Q5108
$7,786
Pegfilgrastim-Jmdb 6 Mg/0.6 Ml
Gross
$8,026
J0897
$7,471
Denosumab 60 MG/ML Syringe
Gross
$7,702
J0897
$7,471
Denosumab 60 MG/ML Syringe
Gross
$7,702
78452
$7,460
Myocard Perf Spect Rest Stress
Gross
$7,691
78452
$7,460
Myocard Perf Spect Rest Stress
Gross
$7,691
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2350 | Ocrelizumab 300 Mg/10 Ml | $88,864 | $86,199 | — | — | 7 |
| J2350 | Ocrelizumab 300 Mg/10 Ml | $88,864 | $86,199 | — | — | 8 |
| J2329 | Ublituximab-Xiiy 150 Mg/6 Ml | $47,176 | $45,761 | — | — | 7 |
| J2329 | Ublituximab-Xiiy 150 Mg/6 Ml | $47,176 | $45,761 | — | — | 8 |
| J9119 | Cemiplimab-Rwlc 350 Mg/7 Ml Vl | $46,640 | $45,241 | — | — | 7 |
| J9119 | Cemiplimab-Rwlc 350 Mg/7 Ml Vl | $46,640 | $45,241 | — | — | 8 |
| J9144 | Daratumumab Hyaluronida 1800Mg | $45,180 | $43,825 | — | — | 7 |
| J9144 | Daratumumab Hyaluronida 1800Mg | $45,180 | $43,825 | — | — | 9 |
| J9316 | Pertuzu-Trastuzu 10 Ml Vial | $40,100 | $38,897 | — | — | 7 |
| J9316 | Pertuzu-Trastuzu 10 Ml Vial | $40,100 | $38,897 | — | — | 9 |
| J3380 | Vedolizumab 300 MG Vial | $39,716 | $38,525 | — | — | 7 |
| J3380 | Vedolizumab 300 MG Vial | $39,716 | $38,525 | — | — | 10 |
| J3101 | Tenecteplase 50 Mg/10 Ml Syrng | $31,584 | $30,637 | — | — | 7 |
| J3101 | Tenecteplase 50 Mg/10 Ml Syrng | $31,584 | $30,637 | — | — | 10 |
| 81162 | BRCA 1&2 Full Gene Seq Del/Dup | $28,538 | $27,682 | — | — | 7 |
| 81162 | BRCA 1&2 Full Gene Seq Del/Dup | $28,538 | $27,682 | — | — | 8 |
| J0717 | Certolizumab Pegol 400 Mg Kit | $22,189 | $21,524 | — | — | 7 |
| J0717 | Certolizumab Pegol 400 Mg Kit | $22,189 | $21,524 | — | — | 8 |
| J0896 | Luspatercept-Aamt 25 Mg Vial | $17,827 | $17,293 | — | — | 7 |
| J0896 | Luspatercept-Aamt 25 Mg Vial | $17,827 | $17,293 | — | — | 8 |
| J2356 | Tezepelumab-EKKO 210 Mg/1.9 Ml | $17,461 | $16,938 | — | — | 7 |
| J2356 | Tezepelumab-EKKO 210 Mg/1.9 Ml | $17,461 | $16,938 | — | — | 8 |
| J2182 | Mepolizumab 100 MG Vial | $13,430 | $13,027 | — | — | 7 |
| J2182 | Mepolizumab 100 MG Vial | $13,430 | $13,027 | — | — | 8 |
| J9205 | Irinotecan Lipos 43MG/10ML Vl | $12,857 | $12,472 | — | — | 7 |
| J9205 | Irinotecan Lipos 43MG/10ML Vl | $12,857 | $12,472 | — | — | 8 |
| J2357 | Omalizumab 300 Mg/2Ml Syringe | $12,614 | $12,236 | — | — | 7 |
| J2357 | Omalizumab 300 Mg/2Ml Syringe | $12,614 | $12,236 | — | — | 8 |
| Q5107 | Bevacizumab-AWWB 400Mg/16Ml Vi | $12,177 | $11,812 | — | — | 7 |
| Q5107 | Bevacizumab-AWWB 400Mg/16Ml Vi | $12,177 | $11,812 | — | — | 8 |
| J3111 | Romosozumab-AQQG 210 Mg/2.34Ml | $11,514 | $11,169 | — | — | 7 |
| J3111 | Romosozumab-AQQG 210 Mg/2.34Ml | $11,514 | $11,169 | — | — | 8 |
| 78815 | PET CT Skull To Mid Thigh Init | $11,125 | $10,791 | — | — | 7 |
| 78815 | PET CT Skull To Mid Thigh Init | $11,125 | $10,791 | — | — | 8 |
| Q5111 | Pegfilgrastim-Cbqv 6 Mg/0.6 Ml | $8,925 | $8,657 | — | — | 7 |
| Q5111 | Pegfilgrastim-Cbqv 6 Mg/0.6 Ml | $8,925 | $8,657 | — | — | 8 |
| J1602 | Golimumab 50 MG/4 ML Vial | $8,842 | $8,577 | — | — | 7 |
| J1602 | Golimumab 50 MG/4 ML Vial | $8,842 | $8,577 | — | — | 8 |
| J9034 | Bendamustine 100 Mg/4 Ml Vial | $8,720 | $8,459 | — | — | 7 |
| J9034 | Bendamustine 100 Mg/4 Ml Vial | $8,720 | $8,459 | — | — | 9 |
| Q5122 | Pegfilgrastim 6 Mg/0.6 Ml Syr | $8,541 | $8,285 | — | — | 7 |
| Q5122 | Pegfilgrastim 6 Mg/0.6 Ml Syr | $8,541 | $8,285 | — | — | 8 |
| 81352 | TP53 Somatic Mutation, Prog | $8,362 | $8,111 | — | — | 7 |
| 81352 | TP53 Somatic Mutation, Prog | $8,362 | $8,111 | — | — | 8 |
| Q5108 | Pegfilgrastim-Jmdb 6 Mg/0.6 Ml | $8,026 | $7,786 | — | — | 7 |
| Q5108 | Pegfilgrastim-Jmdb 6 Mg/0.6 Ml | $8,026 | $7,786 | — | — | 10 |
| J0897 | Denosumab 60 MG/ML Syringe | $7,702 | $7,471 | — | — | 7 |
| J0897 | Denosumab 60 MG/ML Syringe | $7,702 | $7,471 | — | — | 8 |
| 78452 | Myocard Perf Spect Rest Stress | $7,691 | $7,460 | — | — | 8 |
| 78452 | Myocard Perf Spect Rest Stress | $7,691 | $7,460 | — | — | 14 |
Showing top 50 of 1,997 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.